方盛制药(603998.SH)：拟以8000万元购买药品专利权

Group 1 - The company Fangsheng Pharmaceutical (603998.SH) plans to acquire the patent rights for the innovative chemical drug IMM-H024, including raw materials and formulations, for a total of RMB 80 million [1] - The acquisition will be made from China Pharmaceutical University and the Institute of Medicinal Research of the Chinese Academy of Medical Sciences [1] - Payment for the acquisition will be made in installments according to agreed milestones [1]